Literature DB >> 19193845

Identification of Candida nivariensis and Candida bracarensis in a large global collection of Candida glabrata isolates: comparison to the literature.

Shawn R Lockhart1, Shawn A Messer, Michael Gherna, Justin A Bishop, William G Merz, Michael A Pfaller, Daniel J Diekema.   

Abstract

We analyzed 1,598 Candida glabrata isolates for the presence of the cryptic species Candida nivariensis and Candida bracarensis. Both species were very rare in this collection (0.2% prevalence), despite the number of isolates analyzed and the global distribution of the isolates. We saw no associated antifungal resistance in C. nivariensis.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19193845      PMCID： PMC2668319          DOI： 10.1128/JCM.02315-08

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus.

Authors:  Julia Alcoba-Flórez; Sebastián Méndez-Alvarez; Josep Cano; Josep Guarro; Eduardo Pérez-Roth; María del Pilar Arévalo
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Catheter-related fungemia due to fluconazole-resistant Candida nivariensis.

Authors:  Shin-ichi Fujita; Yasuko Senda; Tikako Okusi; Yumi Ota; Hideaki Takada; Kazunori Yamada; Mitsuhiro Kawano
Journal:  J Clin Microbiol       Date:  2007-07-25       Impact factor: 5.948

4.  Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis.

Authors:  Retno Wahyuningsih; Ivo N SahBandar; Bart Theelen; Ferry Hagen; Gé Poot; Jacques F Meis; Anna Rozalyani; Ridhawati Sjam; Djoko Widodo; Samsuridjal Djauzi; Teun Boekhout
Journal:  J Clin Microbiol       Date:  2007-11-14       Impact factor: 5.948

5.  Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

6.  PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast.

Authors:  Julia Alcoba-Flórez; María del Pilar Arévalo; F Javier González-Paredes; Josep Cano; Josep Guarro; Eduardo Pérez-Roth; Sebastián Méndez-Alvarez
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

7.  Candida bracarensis sp. nov., a novel anamorphic yeast species phenotypically similar to Candida glabrata.

Authors:  Alexandra Correia; Paula Sampaio; Steve James; Célia Pais
Journal:  Int J Syst Evol Microbiol       Date:  2006-01       Impact factor: 2.747

8.  Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR.

Authors:  Guizhen Luo; Thomas G Mitchell
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

9.  Candida bracarensis detected among isolates of Candida glabrata by peptide nucleic acid fluorescence in situ hybridization: susceptibility data and documentation of presumed infection.

Authors:  Justin A Bishop; Nancy Chase; Shelley S Magill; Cletus P Kurtzman; Mark J Fiandaca; William G Merz
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

10.  Candida nivariensis, an emerging pathogenic fungus with multidrug resistance to antifungal agents.

Authors:  Andrew M Borman; Rebecca Petch; Christopher J Linton; Michael D Palmer; Paul D Bridge; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2008-01-16       Impact factor: 5.948
View more
  39 in total

Review 1.  Candida nivariensis as a New Emergent Agent of Vulvovaginal Candidiasis: Description of Cases and Review of Published Studies.

Authors:  Pilar Aznar-Marin; Fátima Galan-Sanchez; Pilar Marin-Casanova; Pedro García-Martos; Manuel Rodríguez-Iglesias
Journal:  Mycopathologia       Date:  2015-12-26       Impact factor: 2.574

2.  Caenorhabditis elegans as a Model System To Assess Candida glabrata, Candida nivariensis, and Candida bracarensis Virulence and Antifungal Efficacy.

Authors:  Ainara Hernando-Ortiz; Estibaliz Mateo; Marcelo Ortega-Riveros; Iker De-la-Pinta; Guillermo Quindós; Elena Eraso
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

3.  Comparative evaluation of BD Phoenix and vitek 2 systems for species identification of common and uncommon pathogenic yeasts.

Authors:  Brunella Posteraro; Alberto Ruggeri; Elena De Carolis; Riccardo Torelli; Antonietta Vella; Flavio De Maio; Walter Ricciardi; Patrizia Posteraro; Maurizio Sanguinetti
Journal:  J Clin Microbiol       Date:  2013-08-21       Impact factor: 5.948

4.  Evaluation of Luminex xTAG fungal analyte-specific reagents for rapid identification of clinically relevant fungi.

Authors:  N Esther Babady; Edwin Miranda; Kathleen A Gilhuley
Journal:  J Clin Microbiol       Date:  2011-08-31       Impact factor: 5.948

5.  Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole.

Authors:  André Moreira; Sónia Silva; Cláudia Botelho; Paula Sampaio; Célia Pais; Mariana Henriques
Journal:  Mycopathologia       Date:  2015-07-16       Impact factor: 2.574

6.  Occurrence and characterization of Candida nivariensis from a culture collection of Candida glabrata clinical isolates in Malaysia.

Authors:  Sun Tee Tay; Azadeh Lotfalikhani; Negar Shafiei Sabet; Sasheela Ponnampalavanar; Sofiah Sulaiman; Shiang Ling Na; Kee Peng Ng
Journal:  Mycopathologia       Date:  2014-07-15       Impact factor: 2.574

7.  Rapid discrimination between Candida glabrata, Candida nivariensis, and Candida bracarensis by use of a singleplex PCR.

Authors:  A Enache-Angoulvant; J Guitard; F Grenouillet; T Martin; P Durrens; C Fairhead; C Hennequin
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

8.  Development of two molecular approaches for differentiation of clinically relevant yeast species closely related to Candida guilliermondii and Candida famata.

Authors:  Xiaobo Feng; Jingsong Wu; Bo Ling; Xianwei Yang; Wanqing Liao; Weihua Pan; Zhirong Yao
Journal:  J Clin Microbiol       Date:  2014-06-20       Impact factor: 5.948

9.  In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods.

Authors:  D J Diekema; S A Messer; L B Boyken; R J Hollis; J Kroeger; S Tendolkar; M A Pfaller
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

10.  Matrix-assisted laser desorption ionization-time of flight mass spectrometry for fast and reliable identification of clinical yeast isolates.

Authors:  G Marklein; M Josten; U Klanke; E Müller; R Horré; T Maier; T Wenzel; M Kostrzewa; G Bierbaum; A Hoerauf; H-G Sahl
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.